March 7, 2017 Exercise better than drugs for cancer fatigue Cancer patients may ease fatigue more effectively with exercise and psychotherapy than with medication, a recent study suggests.
March 2, 2017 Obesity strongly linked to 11 types of cancer People who are obese have a greater risk of developing and dying from several types of cancer including malignancies of the breast, ovary, kidney, pancreas, colon, rectum and bone marrow, a research review confirms.
February 28, 2017 Colorectal cancer rates rise sharply in younger US adults Colorectal cancer rates are on the rise among millennials and Gen Xers in the U.S., a new study finds.
February 23, 2017 Many US cancer patients struggle to afford life-saving medications As cancer drug costs rise, U.S. cancer patients are more likely than other medical patients to struggle with paying for prescription medications, according to a recent study.
February 15, 2017 With colon cancer, smokers may be less likely to survive Current smokers diagnosed with colorectal cancer are more likely to die from it than former smokers or people who never tried cigarettes, a recent study suggests.
January 23, 2017 Cancer patients with depression have resources Reuters Health - Cancer patients who experience depression can use both therapy and lifestyle tools to help support their mental health, according to a new patient resource from the JAMA Oncology journal.
January 5, 2017 Hospice care linked to higher family satisfaction Families of terminally ill cancer patients may be more satisfied with the end-of-life treatment their loved ones receive when it involves hospice care, a recent study suggests.
January 3, 2017 Life-extending capacity of new cancer drugs varies widely Drugs recently approved around the world to fight cancer increased patients' overall survival, but benefits vary depending on the drug, a new study shows.
December 15, 2016 Aspirin may reduce risk for colorectal cancer A new study says aspirin helps protect against heart attacks and colorectal cancer.
December 5, 2016 Cancer drugs may remain approved despite lack of benefit In the United States, cancer drugs are sometimes approved through sped-up processes - and they often stay approved even if later studies show them to be inferior to other options or even worse than doing nothing, a new study found.